Delivery Order SPE2DE21D0029-SPE2D626F0010
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $3,573.30 fixed-price delivery order to Becton, Dickinson and Company (BD), Infectious Disease Systems division, on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and represents a task order under BD's existing federal contract vehicles. The work will be performed at BD's facility in Sparks Glencoe, Maryland. BD, a global medical technology...
- Becton, Dickinson and Company (BD) was awarded a delivery order valued at $225,791.91 on September 24, 2025, for other medical supplies and equipment. The contract is a firm fixed-price delivery order with no small business set-aside designation, with an ultimate completion date of October 29, 2026. Performance will take place at BD's facility in Franklin Lakes, New Jersey. The contract is funded by the Medical Supply Chain, a defense-focused federal agency, reflecting BD's ongoing role as a...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $565,008.73 to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and supplies. The contract, which has an ultimate completion date of October 30, 2023, is for the provision of various medical products classified as "OTHER MEDICAL." This award is not associated with any set-aside program. BD has received numerous federal contracts and...
- This is a federal contract award from the Medical Supply Chain agency of the Department of Defense to Becton, Dickinson & Co (BD), a global medical technology manufacturer. The $3,589.06 firm fixed-price delivery order is for the provision of unspecified medical supplies, with an ultimate completion date of January 30, 2025. The contract is not set aside for any specific business category. BD is the prime contractor and has previously been awarded multiple Indefinite Delivery/Indefinite...
- Becton, Dickinson and Company (BD), through its Infectious Disease Systems (IDS) division, was awarded a six-month bridge contract valued at $53,996.97 by the Department of Defense Medical Command for microbiology reagents, supplies, and testing equipment to support operations at Fort Belvoir, Virginia. The contract, awarded on October 1, 2025, under the designation W91YTZ20F0276, is structured as a firm fixed-price purchase order with no small business set-aside designation, reflecting BD's...
- Becton, Dickinson and Company's Infectious Diseases Systems division received a delivery order valued at $1,361.04 for the KIT AFFIRM VPIII CLINICAL from the Defense Health Agency's Medical Supply Chain division. Awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation. The work will be performed in Sparks Glencoe, Maryland. This delivery order represents a task order...
- Becton, Dickinson and Company's Infectious Diseases Systems (IDS) division received a $28,934.87 firm fixed price contract award from the Defense Health Agency on June 5, 2020, with performance completion scheduled for May 31, 2021. This Blanket Purchase Agreement (BPA) call covers Becton Dickinson reagents and consumables for Fort Belvoir Hospital, specifically aspartate aminotransferase test indicators and pipette tips for the Phoenix Automatic Microbiology System, along with associated...
- This federal contract award was made by the Defense Logistics Agency Troop Support Medical to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The $652,075.38 firm fixed price delivery order contract does not have a set-aside designation. BD has received numerous federal contract awards, including a $3 million contract with the Department of Veterans Affairs (VA) for COVID-19 diagnostic testing reagents, a $143 million blanket...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and supplies. The $171,325.80 firm-fixed-price delivery order is for other unspecified medical products, with a period of performance through October 30, 2023. The contract has no set-aside designation. BD, which also does business as BD, is an experienced federal contractor that has received numerous awards from...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D626F0010Delivery Order
Becton, Dickinson and Company (BD), through its Infectious Disease Systems (IDS) division, was awarded a delivery order valued at $2,143.98 by the Department of Defense's Medical Supply Chain on October 1, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by October 23, 2025, and will be performed at BD's facility in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, reflecting BD's established competitive position as a leading provider of medical diagnostic equipment and laboratory solutions to federal agencies. This delivery order represents a task order issued under one of BD's existing Indefinite Delivery/Indefinite Quantity contract vehicles with the Department of Defense or related defense health entities. As a global medical technology manufacturer, BD has demonstrated consistent capability in supplying specialized diagnostic equipment, laboratory instruments, and reagents to the Defense Health Agency and other Department of Defense components. The company's extensive portfolio of federal contracts and blanket purchase agreements across multiple agencies—including the Department of Veterans Affairs, National Institutes of Health, and Centers for Disease Control and Prevention—underscores its role as a critical supplier of advanced medical diagnostic technologies to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/1/25 |